Elevated troponin I is associated with a worse long-term prognosis in patients undergoing beating-heart coronary

Kang Min Kim1, Sang Yoon Kim1, Joon Chul Jung1

  • 1Department of Thoracic and Cardiovascular Surgery, Seoul National University Bundang Hospital, Gyeonggi-do, Republic of Korea.

Insights

Elevated troponin I levels after beating-heart coronary artery bypass grafting (CABG) predict worse long-term survival. Conventional CABG showed no such association, indicating technique-specific risk stratification is crucial for cardiac surgery outcomes.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Biomarkers

Background:

  • Coronary artery bypass grafting (CABG) is a common cardiac surgery procedure.
  • Troponin I is a biomarker for myocardial injury.
  • The prognostic value of elevated troponin I levels post-CABG requires further investigation.

Purpose of the Study:

  • To investigate the impact of elevated postoperative peak troponin I (ppTnI) levels on long-term outcomes after CABG.
  • To compare the prognostic significance of ppTnI between conventional CABG and beating-heart CABG techniques.

Main Methods:

  • A cohort of 996 patients undergoing elective isolated CABG for stable or unstable angina was analyzed.
  • Patients were stratified into higher and lower ppTnI groups based on the 80th percentile.
  • Long-term clinical outcomes, including 10-year overall survival, were assessed.

Main Results:

  • Median ppTnI was significantly higher in conventional CABG compared to beating-heart CABG (4.04 vs 1.24 ng/ml).
  • In beating-heart CABG, patients with ppTnI ≥ 3.3 ng/ml (80th percentile) had significantly worse 10-year survival (64% vs 73%).
  • Elevated ppTnI was identified as a risk factor for overall death in beating-heart CABG (HR: 1.505, P=0.040).

Conclusions:

  • Higher postoperative peak troponin I levels are associated with worse long-term survival specifically in patients undergoing beating-heart CABG.
  • This association was not observed in patients who underwent conventional CABG.
  • Risk stratification based on troponin levels may be technique-dependent in CABG surgery.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
16
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
214
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
43
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
18
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
30
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
16